Kaléo launches government biz unit
Richmond-based Kaléo on Thursday announced the formation of a new government business unit to focus on domestic and international procurement of the company’s system to reverse the effect of weaponized opioids as well as to provide access to it for military and civilian stockpiles. Kaléo’s Rapid Opioid Countermeasure System (ROCS) is a 10 mg Naloxone […]
Richmond pharma company Kaléo acquired
New York-based Marathon Asset Management LP announced Monday it has entered into a definitive agreement to acquire Richmond-based privately held pharmaceutical company Kaléo Inc., which is known for making injectors to treat allergic anaphylaxis and opioids overdoses. The total base purchase price is approximately $310 million in cash, less certain adjustments and includes potential net […[...]